INTERNATIONAL PATENT: CHINA PHARMACEUTICAL UNIVERSITY, 中国药科大学 FILES APPLICATION FOR "HETEROBIFUNCTIONAL COMPOUND FOR TARGETED DEGRADATION OF BRD4 BASED ON HSP70, PREPARATION AND USE"

GENEVA, April 17 -- CHINA PHARMACEUTICAL UNIVERSITY (NO.24 TongJiaXiang, Gulou DistrictNanjing, Jiangsu 210009), 中国药科大学 (中国江苏省南京市鼓楼区童家巷24号) filed a patent application (PCT/CN2025/088904) for "HETEROBIFUNCTIONAL COMPOUND FOR TARGETED DEGRADATION OF BRD4 BASED ON HSP70, PREPARATION, AND USE" on Apr 15, 2025. With publication no. WO/2026/076912, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO). ...